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Malaria and leishmaniasis are life-threatening human parasitosis caused by protozoa-infected insect vectors. 
In most of affected countries, the expansive and hazardous therapies available to fight protozoan infections 
are generally harmed by the spread of drug resistance phenomena upon prolonged treatments. This scenario 
highlights the need of novel antiprotozoal agents hopefully able to act trough new mechanism(s) of action. 
Interestingly, the fat-soluble antimycobacterial drug Clofazimine (Figure 1) was reported to exhibit a 
moderate antiprotozoal action and some interesting antileishmanial in vitro and in vivo effects were reported 
in few preliminary, yet promising, studies.1,4  
Intrigued by these results, we have previously prepared a series of basic Clofazimine analogues which 
demonstrated the beneficial effects of the introduction of a basic head on the antiprotozoal activity.5 Here, 
to further investigate the role of balancing between the lipo- and hydrophilicity on the antiparasitic activity 
of these riminophenazines, we report the synthesis and the in vitro evaluation as leishmanicidal (L. tropica 
and L. infantum promastigotes) and antiplasmodial (chloroquine sensitive and resistant P. falciparum strains) 
agents of a family of hydrophilic C-2 aminopyridinyl substituted riminophenazines, bearing in C-3 differently 
decorated basic side chains (Figure 1). 
 
 
Figure 1: Structures of Clofazimine and C-2 aminopyridine substituted riminophenazine analogues. 
 
Results showed that most of the new compounds potently inhibited the growth of protozoa with IC50 in the 
high nanomolar range and underlined the key role of the hydrophilic C-2 aminopyridinyl moiety to improve 
the leishmanicidal activity. In addition, the length and the nature of the basic side chain differently influenced 
the antiprotozoal activity and the selectivity index versus mammalian cells, providing useful information for 
further structural optimizations. 
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